08Aug
FDA Releases New Warning Letter on Human and Animal Hemp CBD Products
On July 22, 2019, the Food and Drug Administration (“FDA”) released its fourth warning letter for cannabidiol (“CBD”) related products since the enactment of the 2018 Federal Farm Bill in December. Though not a formal action or rule-making by the...
By:
Miller & Martin PLLC
Related
Who's the "swing vote," the "parade of horribles," and more. I'm sorry that I haven't blogged latel...
Read More >
States across the country enacted new legislation that impacts employers in the coming year. Below a...
Read More >
In its 2012 Hosanna-Tabor decision, the U.S. Supreme Court first recognized the existence of a “min...
Read More >
A 360-degree view of compliance is an effort to incorporate your compliance identity into a holistic...
Read More >
In Dakota, Minnesota and Eastern Railroad Corp. v. the Department of Labor, No. 18-2888 (8th Cir. Ja...
Read More >
In today’s edition of Daily Compliance News: 1. What is risk? (Lesson #365,333) (NYT) 2. Internal ...
Read More >